Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Increasing daily steps through tailored communication

Official title: Efficacy of a Tailored Communication Intervention Aimed At Increasing the Number of Daily Steps

Run by University of Milano Bicocca · NCT05620888 · Data updated 2026-11-12

This study is testing whether a mobile app that sends personalized messages can help inactive adults walk more and reach a daily goal of 7,000 steps.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment255 (estimated)
SponsorUniversity of Milano Bicocca
Academic / other
Locations1 site (Milan, MI)
StatusRecruiting
StartedOctober 3, 2022
Main results expectedSeptember 30, 2024
Study endsJune 2025
Registry record updatedDecember 9, 2024
Trial IDNCT05620888 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy, sedentary adults who own a smartphone and are willing to engage in a 30-day walking program.

Probably not a fit

Patients who are already active, taking at least 7,000 steps daily, or have medical conditions that restrict physical activity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention evaluates the effectiveness of a mobile app designed to promote walking behavior among sedentary adults. Over 30 days, participants will receive either tailored or non-tailored messages aimed at increasing their daily step count to 7,000 steps. The study will assess changes in attitudes, self-efficacy, and social support before and after the intervention, comparing the physical activity levels of those receiving messages to a control group. The goal is to determine which type of communication is more effective in fostering behavior change.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance physical activity levels among sedentary individuals, improving overall health outcomes.

How similar studies have gone: Previous studies have shown that tailored communication can effectively promote behavior change, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants from the general population, in good health and sedentary
* A level of education sufficient to understand the procedures of the study and to use a smartphone
* Having a smartphone

Exclusion Criteria:

* The participant always (or almost always) takes at least 7,000 steps a day
* The participant achieves an IPAQ score equal to or greater than 3000 MET-min / week
* The participant has symptoms or pathologies that could represent a contraindication to the physical activity proposed by the study. In particular
* Cardiovascular diseases for which physical activity is allowed only under medical supervision
* Chest pain during daily activities
* Drug treatment for cardiovascular diseases
* Severe arterial hypertension not pharmacologically controlled
* Episodes of loss of consciousness within the past 12 months
* Osteoarticular disorders that could be aggravated by a change in the level of physical activity
* Fractures of the lower limbs, vertebrae, or pelvis in the past six months
* Walking difficulty
* Respiratory insufficiency

Where it's running

  • University of Milano-Bicocca
    Milan, Mi, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.